By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem announced after the close of the market on Monday that revenues during its fiscal first quarter rose a fraction of 1 percent and that it is developing two molecular diagnostic platforms as part of a strategy to move to "higher value products and systems directed at the non-academic market segment."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: factors affecting the success of whole-genome sequencing for routine clinical diagnosis, and more.

A large meta-analysis from an international team reports that nature and nurture have about an equal overall influence on human traits.

The Lasker Foundation's Claire Pomeroy laments the state of NIH funding at Forbes.

Social media is changing how scientists discuss research, as tweets from University of Chicago's Yoav Gilad about a Mouse ENCODE paper have shown, Nature reports.